Anti-cancer radiopharmaceuticals.

PET Radiopharmaceuticals.

Tumour imaging radiopharmaceuticals.

Adverse reactions to radiopharmaceuticals.

[Nuclear medicine and radiopharmaceuticals].

Radiopharmaceuticals labelled with technetium.

Effective dose from radiopharmaceuticals.

Radiopharmaceuticals in breastfeeding.

Patient radiation doses from radiopharmaceuticals.

Cancer-targeted therapies and radiopharmaceuticals.

Electrolytical labeling of 99mTc radiopharmaceuticals.

The clinical application of radiopharmaceuticals.

Radiopharmaceuticals as probes to characterize tumour tissue.

188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy.

Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Gallium-67 and indium-111 radiopharmaceuticals.

New methods for introducing 75Se into radiopharmaceuticals.

Nonosseous accumulation of bone-seeking radiopharmaceuticals.

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.

Problems associated with stannous 99mTc-radiopharmaceuticals.

Potential radiopharmaceuticals labeled with titanium-45.

Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview.

Lipophilic 99mTc-nitride radiopharmaceuticals as potential myocardial imaging agents.

Altered biodistribution of radiopharmaceuticals used in bone scintigraphy.

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.

Suggest Documents

PET Radiopharmaceuticals.

Tumour imaging radiopharmaceuticals.

Adverse reactions to radiopharmaceuticals.

[Nuclear medicine and radiopharmaceuticals].

Radiopharmaceuticals labelled with technetium.

Effective dose from radiopharmaceuticals.

Radiopharmaceuticals in breastfeeding.

Patient radiation doses from radiopharmaceuticals.

Cancer-targeted therapies and radiopharmaceuticals.

Electrolytical labeling of 99mTc radiopharmaceuticals.

The clinical application of radiopharmaceuticals.

Radiopharmaceuticals as probes to characterize tumour tissue.

188Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy.

Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Gallium-67 and indium-111 radiopharmaceuticals.

New methods for introducing 75Se into radiopharmaceuticals.

Nonosseous accumulation of bone-seeking radiopharmaceuticals.

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.

Problems associated with stannous 99mTc-radiopharmaceuticals.

Potential radiopharmaceuticals labeled with titanium-45.

Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview.

Lipophilic 99mTc-nitride radiopharmaceuticals as potential myocardial imaging agents.

Altered biodistribution of radiopharmaceuticals used in bone scintigraphy.

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.

Anti-cancer radiopharmaceuticals.

Recommend Documents

Follow Us